Novartis Takes Fight To The FDA After US Entresto Generic Approval

Originator Cites Labeling Carve-Outs And ‘Same Active Ingredient’ Requirements

 
• By Dean Rudge
  
Lawsuits magnifying glass
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin